Five considerations for adopting AI in clinical study build workflows
Artificial intelligence (AI) is becoming widely adopted in clinical data management, but the most persuasive use cases are rarely the…
Artificial intelligence (AI) is becoming widely adopted in clinical data management, but the most persuasive use cases are rarely the…
For years, biopharma has accumulated vast volumes of data. Now, as the industry races toward an AI-driven future, that data…
Post-marketing approval studies in clinical research for cancer typically suffer from poor engagement and protracted timelines – driving up costs…
The pharmaceutical industry is investing heavily in therapies capable of delivering high-potent treatments to diseased cells while limiting damage to…
Traditional approaches to patient-trial matching often rely solely on structured data, leading to inaccurate eligibility lists and missed opportunities to…
This is the first episode in our second season exploring the evolving landscape of real-world data and its role in…
As clinical trials become more digitalised, the data landscape is expanding faster than the processes designed to control it. Electronic…
Israel has a robust and growing clinical trials ecosystem. This podcast explores the factors that what make Israel such an…
Clinical trials are expensive, time-sensitive, and closely monitored, with sponsors and contract research organisations (CROs) under pressure to run studies…
Saudi Arabia is primed to emerge as the Middle East’s key hub for clinical trials, driven by both sustained state…